Understanding Australia’s Real-Time Prescription Monitoring (RTPM) Systems
When it comes to the safe prescribing and dispensing of medications within Australia, prescribers and pharmacists must monitor patient prescriptions prior to prescribing and dispensing – this is where the Real-Time Prescription Monitoring (RTPM) systems come in that record, in real time, when a monitored medicine is prescribed or dispensed anywhere in the country (ScriptCheckWA, 2026).
Each time a prescription is written or filled, that information is captured in the relevant jurisdiction's database and made instantly visible to other prescribers and pharmacists treating the same patient – giving them a live view of a patient's recent prescription history rather than relying on what the patient reports (ScriptCheckWA, 2023).
As it applies to medicinal cannabis products prescribed in Australia, these medications fall under one of two categories – either schedule 4 or schedule 8 medications (Medicinal cannabis prescribing, n.d.). Because of this, RTPM systems are vital digital health tools that help doctors and pharmacists make safer clinical decisions and prevent medication-related harm (ScriptCheckWA, 2026).
As Australia’s healthcare system operates across different jurisdictions, there isn't a single portal for every healthcare professional to login into. Instead, the system is a collaborative effort broken down into a mix of national infrastructure and state-specific platforms.
For medicinal cannabis prescribers or pharmacists dispensing these medications, checking these systems is a crucial professional responsibility alongside obtaining the necessary Therapeutic Goods Administration (TGA) approvals.
So whether you’re a prescriber or pharmacist navigating the medicinal cannabis landscape, here is the complete breakdown of the RTPM systems at both the federal and state/territory levels –
The Federal and National Infrastructure
National Real Time Prescription Monitoring (RTPM) / National Data Exchange (NDE): RTPM & NDE is the national infrastructure that connects the individual state and territory systems behind the scenes. Rather than a standalone platform that prescribers log into directly, the NDE securely manages the flow of real-time data across borders, ensuring a patient's prescription history can be tracked safely and consistently.
State and Territory-Specific Systems
While the federal infrastructure connects the data, each state and territory operates its own unique RTPM system. For schedule 4 and schedule 8 medicinal cannabis products, participation rules vary.
However, regulators like AHPRA expect prescribers and pharmacists to manage patients just as carefully and diligently when prescribing these products as they do when prescribing opioids and other medications (AHPRA, 2025; AHPRA, n.d.; Medical Board of Australia, 2025).
Here is the complete list of platforms across the country:
Australian Capital Territory (ACT): Canberra Script
New South Wales (NSW): SafeScript NSW
Northern Territory (NT): NTScript
Queensland (QLD): QScript
South Australia (SA): ScriptCheckSA
Tasmania (TAS): TasScript
Victoria (VIC): SafeScript (Victoria State Government Department of Health, 2026)
Western Australia (WA): ScriptCheckWA (WA Health, 2023)
How State RTPM Systems Operate for Medicinal Cannabis
While each state manages its own system, these platforms share very similar mechanics.
Integration and Real-Time Data Collection: Each of these systems collect data automatically. Whenever a prescription for a medication is issued or dispensed, the state's database is updated in real time.
The Traffic Light Notification System: When a prescriber or pharmacist accesses the system, they often see a "traffic light" alert. A red or amber alert might pop up if a patient is sourcing medicinal cannabis from multiple prescribers, or if they are taking medicinal cannabis in combination with other schedule 8 medications.
A Tool for Support, Not a Barrier: RTPM platforms are clinical decision-support tools. An alert does not automatically prevent a prescriber from prescribing medications if they believe it is clinically appropriate. The primary goal is to facilitate a thorough assessment, ensure continuity of care, and keep patients safe.Learn More
Learn More
EQWELLIBRIYUM offers end-to-end consulting for organisations navigating the medicinal cannabis market in Australia. With strategic insights and operational frameworks designed to help you thrive, we’re here to help you. Learn more by contacting us today at hello@eqwellibriyum.com.
References
AHPRA, 2025. Guidance on medicinal cannabis prescribing targets unsafe practice. [online] Nursing and Midwifery Board of Australia. Available at: https://www.nursingmidwiferyboard.gov.au/News/2025-07-09-Medicinal-cannabis-guidance
AHPRA, n.d. Medicinal cannabis prescribing. [online] Ahpra. Available at: https://www.ahpra.gov.au/Resources/Medicinal-cannabis-prescribing
Medical Board of Australia, 2025. Guidance on medicinal cannabis targets unsafe supply. [online] Medical Board of Australia. Available at: https://www.medicalboard.gov.au/sitecore/content/Home/News/2025-09-23-Medicinal-cannabis-guidance.aspx
Victoria State Government Department of Health, 2026. SafeScript for prescribers and pharmacists. [online] Available at: https://www.health.vic.gov.au/safescript/safescript-for-prescribers-and-pharmacists
WA Health, 2023. ScriptCheckWA. [online] Available at: https://www.health.wa.gov.au/articles/s_t/scriptcheckwa